Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Patty Brisben Foundation For Women's Sexual Health | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.
The purpose of this research is to study the effectiveness of an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning. This study consists of attending a group educational session followed by a one-on-one telephone counseling session.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Support Group | Experimental |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Group Session | Behavioral |
| ||
| Telephone Coaching Session |
| Measure | Description | Time Frame |
|---|---|---|
| Change in sexual dysfunction will be assessed by change on the Female Sexual Function Index (FSFI). | Baseline, 2 month Post Intervention, 6 Month Post Intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Change in sexual self-efficacy will be assessed by change on the Sexual Self-Efficacy Scale | Baseline, 2 Month Post Intervention, 6 Month Post Intervention | |
| Improvement in sexual knowledge will be assessed by change on the Sexual Knowledge after Ovarian Cancer questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sharon Bober, Ph.D | Dana-Farber Cancer Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | ||
| Dana Farber Cancer Institute |
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Webinar | Behavioral |
|
| Baseline, 2 Month Post Intervention, 6 Month Post Intervention |
| Change in psychological distress will be assessed by change on the BSI-18 (Brief Symptom Inventory) | Baseline, 2 Month Post Intervention, 6 Month Post Intervention |
| Feasibility of conducting a group sexual health intervention via webinar format will be assessed with descriptive data and qualitative feedback from participants | To explore and describe women's experience of webinar platform. | Baseline, 2 Month Post Intervention, 6 Month Post Intervention |
| Boston |
| Massachusetts |
| 02115 |
| United States |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |